Simone Lista

Summary

Country: Italy

Publications

  1. doi request reprint Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease
    Simone Lista
    Department of Psychiatry, Psychotherapy and Psychosomatics, Martin Luther University Halle Wittenberg, Julius Kühn Straße 7, 06112, Halle Saale, Germany
    Methods Mol Biol 1303:49-67. 2016
  2. doi request reprint Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies
    S Lista
    S Lista, Sorbonne Universités, Universite Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d Alzheimer IM2A and Institut du Cerveau et de la Moelle épinière ICM, Departement de Neurologie, Hopital de la Pitie Salpetriere, Paris, France
    J Nutr Health Aging 19:154-63. 2015
  3. doi request reprint Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments
    Simone Lista
    Departement de Neurologie, institut de la mémoire et de la maladie d Alzheimer IM2A, Pavillon François Lhermitte, Hopital de la Salpetriere, Universite Pierre et Marie Curie, 47 Boulevard de l Hopital, 75013, Paris, France
    J Neurol 261:1234-43. 2014
  4. doi request reprint CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Goethe University, Frankfurt am Main, Germany Electronic address
    Alzheimers Dement 10:381-92. 2014
  5. ncbi request reprint Imaging epigenetics in Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Goethe University, Frankfurt am Main, Germany
    Curr Pharm Des 19:6393-415. 2013
  6. doi request reprint Blood and plasma-based proteomic biomarker research in Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt am Main, Germany
    Prog Neurobiol 101:1-17. 2013
  7. doi request reprint Biological and methodical challenges of blood-based proteomics in the field of neurological research
    Simone Lista
    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt am Main, Germany
    Prog Neurobiol 101:18-34. 2013
  8. doi request reprint Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
    Bruno Dubois
    Institute of Memory and Alzheimer s Disease IM2A and Brain and Spine Institute ICM UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitie Salpetriere University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France Electronic address
    Alzheimers Dement 12:292-323. 2016
  9. doi request reprint Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
    Harald Hampel
    Universite Pierre et Marie Curie, Departement de Neurologie, institut de la mémoire et de la maladie d Alzheimer IM2A, Pavillon François Lhermitte, Hopital de la Salpetriere, Paris, France Electronic address
    Biochem Pharmacol 88:426-49. 2014
  10. doi request reprint Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease
    Enrica Cavedo
    Universite Pierre et Marie Curie, 47 Blvd de l Hopital, 75013 Paris, France
    J Clin Psychiatry 77:e1631-e1638. 2016

Collaborators

Detail Information

Publications19

  1. doi request reprint Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease
    Simone Lista
    Department of Psychiatry, Psychotherapy and Psychosomatics, Martin Luther University Halle Wittenberg, Julius Kühn Straße 7, 06112, Halle Saale, Germany
    Methods Mol Biol 1303:49-67. 2016
    ..The approach propped here, combining longitudinal studies with the systems biology paradigm, will create a more effective and comprehensive framework for development of prevention therapies in AD. ..
  2. doi request reprint Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies
    S Lista
    S Lista, Sorbonne Universités, Universite Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d Alzheimer IM2A and Institut du Cerveau et de la Moelle épinière ICM, Departement de Neurologie, Hopital de la Pitie Salpetriere, Paris, France
    J Nutr Health Aging 19:154-63. 2015
    ..We will also review the role of biomarkers to identify subgroups of patients who would most likely benefit from secondary prevention strategies, and to evaluate the benefit of treatment in such patients. ..
  3. doi request reprint Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments
    Simone Lista
    Departement de Neurologie, institut de la mémoire et de la maladie d Alzheimer IM2A, Pavillon François Lhermitte, Hopital de la Salpetriere, Universite Pierre et Marie Curie, 47 Boulevard de l Hopital, 75013, Paris, France
    J Neurol 261:1234-43. 2014
    ....
  4. doi request reprint CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Goethe University, Frankfurt am Main, Germany Electronic address
    Alzheimers Dement 10:381-92. 2014
    ....
  5. ncbi request reprint Imaging epigenetics in Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Goethe University, Frankfurt am Main, Germany
    Curr Pharm Des 19:6393-415. 2013
    ..This knowledge may open doors for the development of novel biomarkers and preventive and disease-modifying treatments. ..
  6. doi request reprint Blood and plasma-based proteomic biomarker research in Alzheimer's disease
    Simone Lista
    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt am Main, Germany
    Prog Neurobiol 101:1-17. 2013
    ..Currently, growing evidence suggests that blood protein signatures are helpful to increase the likelihood of successful diagnosis of AD. Accordingly, this area of research promises to yield exciting results in the next future...
  7. doi request reprint Biological and methodical challenges of blood-based proteomics in the field of neurological research
    Simone Lista
    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt am Main, Germany
    Prog Neurobiol 101:18-34. 2013
    ..Finally, the potential usefulness of bioinformatics--allowing for the assembly, store, and processing of data--as well as its contribution to the execution of proteomic studies will be critically discussed...
  8. doi request reprint Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
    Bruno Dubois
    Institute of Memory and Alzheimer s Disease IM2A and Brain and Spine Institute ICM UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitie Salpetriere University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France Electronic address
    Alzheimers Dement 12:292-323. 2016
    ..This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations. ..
  9. doi request reprint Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
    Harald Hampel
    Universite Pierre et Marie Curie, Departement de Neurologie, institut de la mémoire et de la maladie d Alzheimer IM2A, Pavillon François Lhermitte, Hopital de la Salpetriere, Paris, France Electronic address
    Biochem Pharmacol 88:426-49. 2014
    ..This perspective summarizes not only present knowledge regarding biological markers but also unresolved questions on the status of surrogate indicators for detection of the disease in asymptomatic people and diagnosis of AD. ..
  10. doi request reprint Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease
    Enrica Cavedo
    Universite Pierre et Marie Curie, 47 Blvd de l Hopital, 75013 Paris, France
    J Clin Psychiatry 77:e1631-e1638. 2016
    ..We investigated the effect of donepezil treatment on cortical thickness in mild cognitively impaired subjects with the amnestic syndrome of the hippocampal type, a prodromal at-risk group for progression to AD dementia...
  11. doi request reprint Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
    Simone Lista
    AXA Research Fund and UPMC Chair, Paris, France
    J Alzheimers Dis 48:S171-91. 2015
    ....
  12. doi request reprint Biomarkers in Sporadic and Familial Alzheimer's Disease
    Simone Lista
    AXA Research Fund and UPMC Chair, Paris, France
    J Alzheimers Dis 47:291-317. 2015
    ....
  13. doi request reprint Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial
    Francesca Di Stefano
    AP HP, Groupe Hospitalier Pitie Salpetriere, Departement de Neurologie, institut de la mémoire et de la maladie d Alzheimer, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Alzheimers Dis 48:793-804. 2015
    ..776 and the optimal cut-off was 42 (se 62.5% , sp 82.26% , PPV 23.20% and NPV 96.24%). This study sets the framework for implementing the FCSRT in clinical and therapeutic trials for efficient subject selection. ..
  14. doi request reprint Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot
    Harald Hampel
    Department of Psychiatry, University of Frankfurt, Frankfurt am Main, Germany
    Alzheimers Dement 8:312-36. 2012
    ....
  15. doi request reprint The phenotypical core of Alzheimer's disease-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study
    Francesca Di Stefano
    Department of Neurology, institut de la mémoire et de la maladie d Alzheimer, centre de référence Démences Rares, Hopital de la Pitie Salpetriere, AP HP, Paris, France Department of Neurology, University of Cagliari, Cagliari, Italy
    Alzheimers Dement 12:786-95. 2016
    ....
  16. doi request reprint Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future
    Harald Hampel
    AXA Research Fund and UPMC Chair, Paris, France
    Expert Rev Neurother 15:83-105. 2015
    ....
  17. doi request reprint Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge
    Harald Hampel
    Department of Psychiatry, Goethe University, Frankfurt am Main, Germany
    Nat Rev Neurol 8:598-600. 2012
    ..A landmark study has proposed a biomarker progression model of dominantly inherited AD, but a complex systems biology and physiology approach is required to translate these findings to sporadic disease...
  18. doi request reprint Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
    Bruno Dubois
    institut de la mémoire et de la maladie d Alzheimer IM2A, Departement de Neurologie, Hopital de la Pitie Salpetriere, AP HP, Paris, France INSERM, CNRS, UMR S975, Institut du Cerveau et de la Moëlle épinière ICM, Paris, France Sorbonne Universités, Universite Pierre et Marie Curie Paris 6, Paris, France Electronic address
    Alzheimers Dement 11:1041-9. 2015
    ..The purpose of this study was to study the effect of donepezil on the rate of hippocampal atrophy in prodromal Alzheimer's disease (AD)...
  19. ncbi request reprint Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease
    Simone Lista
    a AXA Research Fund and UPMC Chair, Paris, France
    Expert Rev Neurother 17:47-57. 2017
    ..Its use may support the development of targeted therapeutic interventions tailored to the individual patient, i.e. 'molecularly' targeted therapies, according to the evolving precision medicine paradigm...